Chlorothiazide Sodium (Akorn, Inc.)
Welcome to the PulseAid listing for the Chlorothiazide Sodium drug offered from Akorn, Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Chlorothiazide Sodium |
SUBSTANCE NAME: | CHLOROTHIAZIDE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2012-08-13 |
END MARKETING DATE: | 0000-00-00 |
Chlorothiazide Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Chlorothiazide Sodium from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2012-08-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-419_8b346dfd-230e-4988-acf0-b460910ac138 |
PRODUCT NDC: | 17478-419 |
APPLICATION NUMBER: | NDA011145 |
Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers: